Clinical Trials List
Protocol NumberMOR202C206
Completed
2021-08-01 - 2024-05-31
Phase II
Recruiting3
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 吳軍毅 Division of Nephrology
- CHENG-HSU CHEN Division of Nephrology
- 蔡尚峰 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Mei-Yi Wu Division of Nephrology
- I-jen Chiu Division of Nephrology
- Yu-Wei Chen Division of Nephrology
- Chia-Te Liao Division of Nephrology
- Li-Yee Hong Division of Nephrology
- Cai-Mei Zheng Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
5 participants
-
Global
44 participants
